OBJECTIVES: The aim of this study was to close ventricular septal defects (VSDs) directly through the chest wall using magnetic resonance imaging (MRI) guidance, without cardiopulmonary bypass, sternotomy, or radiation exposure. BACKGROUND: Surgical, percutaneous, and hybrid management of VSD each have limitations and known morbidity. METHODS: Percutaneous muscular VSDs were created in 10 naive Yorkshire swine using a transjugular laser catheter. Under real-time MRI guidance, a direct transthoracic vascular access sheath was introduced through the chest into the heart along a trajectory suitable for VSD access and closure. Through this transthoracic sheath, muscular VSDs were occluded using a commercial nitinol device. Finally, the right ventricular free wall was closed using a commercial collagen plug intended for arterial closure. RESULTS: Anterior, posterior, and mid-muscular VSDs (6.8 ± 1.8 mm) were created. VSDs were closed successfully in all animals. The transthoracic access sheath was displaced in 2, both fatal. Thereafter, we tested an intracameral retention sheath to prevent this complication. Right ventricular access ports were closed successfully in all, and after as many as 30 days, healed successfully. CONCLUSIONS: Real-time MRI guidance allowed closed-chest transthoracic perventricular muscular VSD closure in a clinically meaningful animal model. Once applied to patients, this approach may avoid traditional surgical, percutaneous, or open-chest transcatheter ("hybrid") risks.
OBJECTIVES: The aim of this study was to close ventricular septal defects (VSDs) directly through the chest wall using magnetic resonance imaging (MRI) guidance, without cardiopulmonary bypass, sternotomy, or radiation exposure. BACKGROUND: Surgical, percutaneous, and hybrid management of VSD each have limitations and known morbidity. METHODS: Percutaneous muscular VSDs were created in 10 naive Yorkshire swine using a transjugular laser catheter. Under real-time MRI guidance, a direct transthoracic vascular access sheath was introduced through the chest into the heart along a trajectory suitable for VSD access and closure. Through this transthoracic sheath, muscular VSDs were occluded using a commercial nitinol device. Finally, the right ventricular free wall was closed using a commercial collagen plug intended for arterial closure. RESULTS: Anterior, posterior, and mid-muscular VSDs (6.8 ± 1.8 mm) were created. VSDs were closed successfully in all animals. The transthoracic access sheath was displaced in 2, both fatal. Thereafter, we tested an intracameral retention sheath to prevent this complication. Right ventricular access ports were closed successfully in all, and after as many as 30 days, healed successfully. CONCLUSIONS: Real-time MRI guidance allowed closed-chest transthoracic perventricular muscular VSD closure in a clinically meaningful animal model. Once applied to patients, this approach may avoid traditional surgical, percutaneous, or open-chest transcatheter ("hybrid") risks.
Authors: Carlos A C Pedra; Simone R F Pedra; Paulo Chaccur; Marcelo Jatene; Rodrigo N Costa; Ziyad M Hijazi; Zahid Amin Journal: Expert Rev Cardiovasc Ther Date: 2010-05
Authors: Luis F Gutiérrez; Ranil de Silva; Cengizhan Ozturk; Merdim Sonmez; Annette M Stine; Amish N Raval; Venkatesh K Raman; Vandana Sachdev; Ronnier J Aviles; Myron A Waclawiw; Elliot R McVeigh; Robert J Lederman Journal: Catheter Cardiovasc Interv Date: 2007-11-15 Impact factor: 2.692
Authors: Kanishka Ratnayaka; Anthony Z Faranesh; Michael A Guttman; Ozgur Kocaturk; Christina E Saikus; Robert J Lederman Journal: J Cardiovasc Magn Reson Date: 2008-12-29 Impact factor: 5.364
Authors: Jamie A Bell; Christina E Saikus; Kanishka Ratnayaka; Israel M Barbash; Anthony Z Faranesh; Dominique N Franson; Merdim Sonmez; Michael C Slack; Robert J Lederman; Ozgur Kocaturk Journal: J Magn Reson Imaging Date: 2012-06-15 Impact factor: 4.813
Authors: Kanishka Ratnayaka; Toby Rogers; William H Schenke; Jonathan R Mazal; Marcus Y Chen; Merdim Sonmez; Michael S Hansen; Ozgur Kocaturk; Anthony Z Faranesh; Robert J Lederman Journal: JACC Cardiovasc Interv Date: 2016-04-13 Impact factor: 11.195
Authors: Kanishka Ratnayaka; Anthony Z Faranesh; Michael S Hansen; Annette M Stine; Majdi Halabi; Israel M Barbash; William H Schenke; Victor J Wright; Laurie P Grant; Peter Kellman; Ozgur Kocaturk; Robert J Lederman Journal: Eur Heart J Date: 2012-08-01 Impact factor: 29.983
Authors: Sophie C Rier; Suzan Vreemann; Wouter H Nijhof; Vincent J H M van Driel; Ivo A C van der Bilt Journal: Ther Adv Cardiovasc Dis Date: 2022 Jan-Dec
Authors: Majdi Halabi; Anthony Z Faranesh; William H Schenke; Victor J Wright; Michael S Hansen; Christina E Saikus; Ozgur Kocaturk; Robert J Lederman; Kanishka Ratnayaka Journal: J Cardiovasc Magn Reson Date: 2013-07-20 Impact factor: 5.364
Authors: Majdi Halabi; Kanishka Ratnayaka; Anthony Z Faranesh; Michael S Hansen; Israel M Barbash; Michael A Eckhaus; Joel R Wilson; Marcus Y Chen; Michael C Slack; Ozgur Kocaturk; William H Schenke; Victor J Wright; Robert J Lederman Journal: J Cardiovasc Magn Reson Date: 2013-01-18 Impact factor: 5.364